miRNAs in stem cell-derived extracellular vesicles for acute kidney injury treatment: comprehensive review of preclinical studies
| Autor: | Quan Hong, Chao-Yang Zhang, Yuan-Jun Yang, Guangyan Cai, Si-Yang Wang, Xiangmei Chen |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
medicine.medical_treatment Medicine (miscellaneous) Review Biology Biochemistry Genetics and Molecular Biology (miscellaneous) lcsh:Biochemistry Extracellular Vesicles 03 medical and health sciences 0302 clinical medicine Immune system microRNA medicine Animals Humans lcsh:QD415-436 Inflammation Regulation of gene expression lcsh:R5-920 Kidney Stem cell Stem Cells Acute kidney injury Cell Biology Stem-cell therapy Acute Kidney Injury medicine.disease MicroRNAs 030104 developmental biology medicine.anatomical_structure Cytoprotection 030220 oncology & carcinogenesis Cancer research Molecular Medicine lcsh:Medicine (General) Function (biology) |
| Zdroj: | Stem Cell Research & Therapy Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-7 (2019) |
| ISSN: | 1757-6512 |
| DOI: | 10.1186/s13287-019-1371-1 |
| Popis: | Stem cell therapy has been applied in many fields. Basic and clinical studies on stem cell therapy for acute kidney injury (AKI) have been conducted. Stem cells have been found to exert renal protection through a variety of mechanisms, such as regulating the immune system and secreting growth factors, cytokines, and extracellular vesicles (EVs). Among them, EVs are considered to be important mediators for stem cell protection because they contain various biological components, including microRNAs (miRNAs). miRNAs are a class of small RNAs that function in posttranscriptional gene regulation. A number of studies have confirmed that miRNAs in stem cell-derived EVs can protect from AKI. miRNAs can enter the injured renal tissue through EVs released from stem cells, thereby exerting anti-inflammatory, anti-apoptotic, anti-fibrotic, and pro-angiogenesis effects on AKI. However, the stem cell sources and AKI models used in these studies have differed. This article will summarize the miRNAs that play a role in kidney protection in stem cell EVs and clarifies the treatment characteristics and mechanisms of different miRNAs. This may provide a reference for clinical practice for acute and chronic kidney diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink